Publicaciones (75) Publicaciones en las que ha participado algún/a investigador/a

2016

  1. A simple approach to obtain hybrid Au-loaded polymeric nanoparticles with a tunable metal load

    Nanoscale, Vol. 8, Núm. 12, pp. 6495-6506

  2. Amikacin loaded PLGA nanoparticles against Pseudomonas aeruginosa

    European Journal of Pharmaceutical Sciences, Vol. 93, pp. 392-398

  3. An increase in plasma homovanillic acid with cocoa extract consumption is associated with the alleviation of depressive symptoms in overweight or obese adults on an energy restricted diet in a randomized controlled trial

    Journal of Nutrition, Vol. 146, Núm. 4, pp. 897S-904S

  4. Bifunctional Chiral Dehydroalanines for Peptide Coupling and Stereoselective S-Michael Addition

    Organic Letters, Vol. 18, Núm. 12, pp. 2796-2799

  5. Bioaccessibility of rutin, caffeic acid and rosmarinic acid: Influence of the in vitro gastrointestinal digestion models

    Journal of Functional Foods, Vol. 26, pp. 428-438

  6. Biocompatible polymer-metal-organic framework composite patches for cutaneous administration of cosmetic molecules

    Journal of Materials Chemistry B, Vol. 4, Núm. 43, pp. 7031-7040

  7. Brain aging and Parkinson's disease: New therapeutic approaches using drug delivery systems

    Maturitas, Vol. 84, pp. 25-31

  8. Brain delivery of microencapsulated GDNF induces functional and structural recovery in parkinsonian monkeys

    Biomaterials, Vol. 110, pp. 11-23

  9. Bringing model-based prediction to oncology clinical practice: A review of Pharmacometrics principles and applications

    Oncologist, Vol. 21, Núm. 2, pp. 220-232

  10. Catheter-based intramyocardial injection of FGF1 or NRG1-loaded MPs improves cardiac function in a preclinical model of ischemia-reperfusion

    Scientific Reports, Vol. 6

  11. Chalcogen containing heterocyclic scaffolds: New hybrids with antitumoral activity

    European Journal of Medicinal Chemistry, Vol. 123, pp. 407-418

  12. Challenges in chagas disease drug discovery: A review

    Current Medicinal Chemistry, Vol. 23, Núm. 28, pp. 3154-3170

  13. Correlation between anti-PD-L1 tumor concentrations and tumor-specific and nonspecific biomarkers in a melanoma mouse model

    Oncotarget, Vol. 7, Núm. 47, pp. 76891-76901

  14. Cyclosporine A lipid nanoparticles for oral administration: Pharmacodynamics and safety evaluation

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 101, pp. 112-118

  15. Cyclosporine A-loaded lipid nanoparticles in inflammatory bowel disease

    International Journal of Pharmaceutics, Vol. 503, Núm. 1-2, pp. 196-198

  16. Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome

    Critical Care, Vol. 20, Núm. 1

  17. Design and synthesis of novel quinoxaline derivatives as potential candidates for treatment of multidrug-resistant and latent tuberculosis

    Bioorganic and Medicinal Chemistry Letters, Vol. 26, Núm. 9, pp. 2188-2193

  18. Design of α-S-Neoglycopeptides Derived from MUC1 with a Flexible and Solvent-Exposed Sugar Moiety

    Journal of Organic Chemistry, Vol. 81, Núm. 14, pp. 5929-5941

  19. Design, Synthesis, and Biological Evaluation of Novel Selenium (Se-NSAID) Molecules as Anticancer Agents

    Journal of Medicinal Chemistry, Vol. 59, Núm. 5, pp. 1946-1959

  20. Development and characterization of polo-like kinase 2 loaded nanoparticles-A novel strategy for (serine-129) phosphorylation of alpha-synuclein

    International Journal of Pharmaceutics, Vol. 514, Núm. 1, pp. 142-149